More vaccines, more infections: Devastating Cleveland study passes peer review

The devastating Cleveland study that found the more COVID vaccines individuals receive, the more likely they are to be infected with COVID — has passed peer review. 

More vaccines, more infections: Devastating Cleveland study passes peer review

Researchers included over 50,000 participants in their study, all who were employees at the Cleveland Clinic in Ohio.

“The association of increased risk of COVID-19 with higher numbers of prior vaccine doses in our study, was unexpected,” researchers stated.

In January, prior to the study passing peer review, several vaccine skeptics disseminated the alarming “pre-print” study. Twitter tagged posts about the pre-print with Community Notes to inform social media users that it hadn’t yet passed peer review.

But now that the study has been peer reviewed, it’s officially a scientific finding that vaccines not only don’t help prevent infection, but they make getting infected more likely — an astonishing hit to the so-called effective vaccines that’s known as “negative efficacy.” 

Compared to unvaccinated individuals:

  • Participants who’d received one Covid vaccine were 1.7 times more likely to test positive for Covid
  • Participants who’d received two Covid vaccines were 2.63 times more likely to test positive for Covid
  • Participants who’d received three Covid vaccines were 3.1 times more likely to test positive for Covid
  • Participants who’d received four or more Covid vaccines were 3.8 times more like to test positive for Covid

Researchers said that a simplistic explanation for the startling results would be that higher-risk individuals received more vaccines. 

“However, the majority of subjects in this study were generally young individuals and all were eligible to have received at least three doses of vaccine by the study start date, and which they had every opportunity to do,” they said. 

In other words, most individuals who had received three shots or less were eligible for more but chose to ignore the CDC’s guidance on staying “up-to-date” on COVID vaccines.

The study showed risks over three months, starting September 12, 2022. This was the first day the bivalent COVID vaccine became available to employees at the clinic. 

Researchers conclude

Researchers concluded the bivalent COVID-19 booster was only 30% effective in preventing infection.

YouTube removed a video of Dr. John Campbell presenting the data to his audience of 2.7 million followers. However, Rumble, an alternative video-sharing platform, kept the video up.

Last summer, most Canadian provinces stopped publishing information about infections according to vaccine status, right around the time the vaccinated population was beginning to show higher rates of infection per capita.

Share this story

Donate now to keep us on the front lines:

Help Keep your News Free

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

[wpp limit=6 order_by='views']


Trending News

Von der Leyen just got re-elected — and chastised in parliament.

Mike Campbell

July 18, 2024

Trending News

Though the Avian Flu’s current H5N1 strain is not a risk to humans, researchers say it “may evolve and cause a human pandemic.”  

TCS Wire

July 2, 2024

Trending News

Pfizer sued by Kansas Attorney General: “Pfizer made multiple misleading statements to deceive the public about its vaccine…”

Mike Campbell

June 28, 2024

Trending News

FAUCI: “If trying to save people’s lives is a crime, then I am guilty.”

Alexa Posa

June 25, 2024

Trending News

The federally-funded Toronto Star, which once wrote “let them die” referring to unvaccinated people, published an article claiming Canadians haven’t lost any freedom.

Alexa Posa

June 21, 2024

Trending News

The coercion and broken promises of COVID vaccines has consequences.

Mike Campbell

June 12, 2024

Want to join the conversation?

Sign up now to be able to like, comment and reply to other members. A full membership to our site includes:

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.